Compare D R Horton Inc (DHI) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
D R Horton Inc vs BIO-TECHNE Corp — how do they compare? D R Horton Inc trades at $149.8 (market cap $42.21B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: D R Horton Inc is far larger — about 3.8× BIO-TECHNE Corp's market cap, and D R Horton Inc pays the higher dividend (1.21%). Which is the better fit depends on your goals.
| DHI | TECH | |
|---|---|---|
Market Cap | $42.21B | $11.12B |
Sector | Consumer Cyclical | Health |
52-Week High | $184.04 | $71.38 |
52-Week Low | $129.82 | $43.31 |
Enterprise Value | $46.93B | $11.20B |
Dividend Yield | 1.21% | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About D R Horton Inc
D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
